A detailed history of Philadelphia Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Philadelphia Trust CO holds 2,714 shares of NVS stock, worth $267,193. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,714
Previous 2,714 -0.0%
Holding current value
$267,193
Previous $289,000 7.96%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

SELL
$92.52 - $104.91 $27,570 - $31,263
-298 Reduced 9.89%
2,714 $274,000
Q1 2022

May 05, 2022

SELL
$80.11 - $90.62 $16,022 - $18,124
-200 Reduced 6.23%
3,012 $264,000
Q4 2018

Feb 13, 2019

SELL
$73.66 - $82.02 $20,109 - $22,391
-273 Reduced 7.83%
3,212 $276,000
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $233,285 - $269,843
3,485 New
3,485 $300,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Philadelphia Trust CO Portfolio

Follow Philadelphia Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Philadelphia Trust CO with notifications on news.